Efficacy and Safety of Human Retinal Progenitor Cells.

Semo, Ma'ayan; Haamedi, Nasrin; Stevanato, Lara; Carter, David; Brooke, Gary; Young, Michael; Coffey, Peter; Sinden, John; Patel, Sara; Vugler, Anthony

Semo, Ma'ayan; Haamedi, Nasrin; Stevanato, Lara; Carter, David; Brooke, Gary; Young, Michael; Coffey, Peter; Sinden, John; Patel, Sara; Vugler, Anthony.

Afiliación

Semo M; Department of Ocular Biology and Therapeutics, UCL-Institute of Ophthalmology, London, UK.
Haamedi N; Department of Ocular Biology and Therapeutics, UCL-Institute of Ophthalmology, London, UK.
Stevanato L; ReNeuron, Guildford, UK.
Carter D; Department of Ocular Biology and Therapeutics, UCL-Institute of Ophthalmology, London, UK.
Brooke G; ReNeuron, Guildford, UK.
Young M; Massachusetts Eye and Ear, Schepens Eye Research Institute, Boston, MA, USA.
Coffey P; Department of Ocular Biology and Therapeutics, UCL-Institute of Ophthalmology, London, UK.
Sinden J; ReNeuron, Guildford, UK.
Patel S; ReNeuron, Guildford, UK.
Vugler A; Department of Ocular Biology and Therapeutics, UCL-Institute of Ophthalmology, London, UK.

Transl Vis Sci Technol ; 5(4): 6, 2016 Jul.

Article en En | MEDLINE | ID: mdl-27486556

Palabras clave

dexamethasone; nestin; retinal degeneration; retinal progenitor cells, human

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Vis Sci Technol Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google